Precision medicine transforms cancer care, enhancing patient outcomes through targeted therapies, yet faces challenges in community access and biomarker testing.
New research uncovers the complex tumor microenvironment in multiple myeloma, revealing unique plasma cell ecosystems that challenge existing treatment approaches.
Networking equipment manufacturer CyberTAN saw its July 2025 revenue drop by 16.69% year-over-year to NT$345 million (approx. US$11.5 million); however,…